Dose-Escalation Study of HTX-034 Following Bunionectomy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This is a Phase 1b/2, randomized, blinded, active-controlled study. Phase 1b will evaluate escalating doses of HTX-034 compared with bupivacaine HCl. Phase 2 will be a dose-expansion phase to evaluate additional subjects treated with the HTX-034 dose selected based on Phase 1b compared with bupivacaine HCl.
Epistemonikos ID: 4f0d2eed740d24a650103e8fda3dee680017b7a6
First added on: May 07, 2024